Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin.
Chennuru
S
S
Baumann
M A
MA
D000368:Aged; D004921:Erythropoietin / Q000009:adverse effects*; D006397:Hematinics / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D012307:Risk Factors; D013792:Thalidomide / Q000009:adverse effects*; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000139:chemically induced*
D006397:Hematinics; D007166:Immunosuppressive Agents; D004921:Erythropoietin; D013792:Thalidomide